A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Clinical trial NCT00774345 · COMPLETED
Trial details
- NCT number
- NCT00774345
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-27
- Primary completion
- 2020-10-27
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.